Breaking News, Financial News

Financial Report: Akorn 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Akorn Inc. Third Quarter Report

3Q Revenues:
$14.5 million (+32%)

3Q Loss: $1.2 million (loss of $3.6 million in 3Q2005)

YTD Revenues: $56.7 million (+68%)

YTD Loss: $0.6 million (loss of $8.0 million in YTD2005)

Comments: Two new contract manufacturing supply agreements were signed, one with GeneraMedix and one with Advanced Vision Research.The two agreements are projected to increase Contract Manufacturing sales by approximately 50% on an annualized basis, beginning in 2007. They are expected to contribute revenue in the fourth quarter of 2006.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters